Laura is currently active as CEO at Cellevate AB. She is a Senior Executive with a passion for developing and implementing company strategy. Laura has global experience in start ups, medium and large organizations and a track record of developing companies and organizations. Laura also has IPO experience from Nasdaq. She is experienced within cancer diagnostics, autoimmunity, laboratory services, biotechnology/bioprocess and medical devices in Europe, USA and Japan.